Related Experiment Videos

Meningococcal disease in the United States--1986. Meningococcal Disease Study Group

R W Pinner1, B G Gellin, W F Bibb

  • 1Division of Bacterial and Mycotic Diseases, Center for Infectious Diseases, Centers for Disease Control, Atlanta, Georgia 30333.

Insights

Active surveillance identified invasive meningococcal disease incidence at 1.3:10(5). Los Angeles County showed the highest rates, with Neisseria meningitidis serogroups B and C being the primary causes.

Area of Science:

  • Epidemiology
  • Microbiology

Background:

  • Invasive meningococcal disease (IMD) remains a significant public health concern.
  • Understanding geographic and serogroup-specific incidence is crucial for targeted interventions.

Purpose of the Study:

  • To conduct active surveillance for IMD in the United States.
  • To determine the incidence and serogroup distribution of IMD across different regions.

Main Methods:

  • Active surveillance was performed in six US areas (approx. 34 million population) during 1986-1987.
  • Incidence rates and serogroup prevalence (B and C) were analyzed.
  • Multilocus enzyme electrophoresis (MEE) was used to characterize Neisseria meningitidis isolates.

Main Results:

  • Overall IMD incidence was 1.3:10(5).
  • Los Angeles County exhibited the highest incidence (1.65:10(5).
  • Serogroups B and C were equally prevalent, with a notable increase in group C disease. Group C predominated in Los Angeles and Tennessee, while less common in Missouri and Oklahoma. MEE identified a prevalent, closely related N. meningitidis strain in Los Angeles associated with elevated disease incidence.

Conclusions:

  • Neisseria meningitidis serogroups B and C are key drivers of invasive meningococcal disease.
  • Geographic variations in serogroup prevalence exist, with implications for public health strategies.
  • Specific N. meningitidis strains may contribute to localized outbreaks of invasive meningococcal disease.

Related Concept Videos